Filtering

Page: () 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 ... 56 ()
OP09: Histological remission and mucosal healing in a randomised, placebo-controlled, phase 2 study of etrasimod in patients with moderately to severely active ulcerative colitisECCO '19
Year: 2019
Authors: Laurent Peyrin-Biroulet
Ulcerative colitis, Disease activity Indices, Mucosal healing, S1P agonist, Histological remission, Mucosal healing
Files: 1
OP10: Systems genomics of ulcerative colitisECCO '19
Year: 2019
Authors: Johanne Brooks
Genetic factors, Ulcerative colitis, Genetics
Files: 1
OP12: Targeting inflammation in ulcerative colitis by inhibiting glucose uptakeECCO '19
Year: 2019
Authors: Roswitha Gropp
Immunology, Lymphocyte, Macrophage, T cell
Files: 1
OP13: Molecular response to ustekinumab in moderate-to-severe ulcerative colitis by serum protein and biopsy gene expression analysisECCO '19
Year: 2019
Authors: Katherine Li
Ulcerative colitis, Ustekinumab, Genetics, Genetic factors
Files: 1
OP17: A molecular measure of inflammation in IBD patients based on transcriptional profiles from 2495 intestinal biopsiesECCO '19
Year: 2019
Authors: Mayte Suarez-Farinas
Crohn’s disease, Ulcerative colitis, CRP and other serum biomarkers, Transcriptomics
Files: 1
OP18: Proactive adalimumab trough measurements increase corticosteroid-free clinical remission in pediatric patients with Crohn’s diseaseECCO '19
Year: 2019
Authors: Amit Assa
Adalimumab, Pharmacokinetics, Treat to target, Paediatric, Outcome measures
Files: 1
OP19: Corticosteroid response rectal gene signature and associated microbial variation in treatment naïve ulcerative colitisECCO '19
Year: 2019
Authors: Yael Haberman
Microbiota, Natural history, Ulcerative colitis, Calprotectin and other faecal biomarkers, Prognosis, Corticosteroids, Infliximab, Vedolizumab, Paediatric, Microbiota, Outcome measures
Files: 1
OP23: CKD-506, a novel histone deacetylase (HDAC) 6 inhibitor, ameliorates colitis in various animal modelsECCO '19
Year: 2019
Authors: Jieun Shin
Epigenetics, Immunology, Macrophage, T cell
Files: 1
OP24: Effectiveness and safety of ustekinumab 90 mg every four weeks in Crohn's diseaseECCO '19
Year: 2019
Authors: Mathurin Fumery
Ustekinumab
Files: 1
OP25: Targeting endoscopic outcomes through combined pharmacokinetic and pharmacodynamic monitoring of infliximab therapy in patients with Crohn’s diseaseECCO '19
Year: 2019
Authors: Erwin Dreesen
Anti-TNF agents, Infliximab, Pharmacokinetics, Treat to target
Files: 1
OP26: Long-term safety of vedolizumab in ulcerative colitis and Crohn’s diseaseECCO '19
Year: 2019
Authors: Remo Panaccione
Vedolizumab
Files: 1
OP29: ST2+/IL-33 responsive cells promote tumorigenesis in colitis-associated colorectal cancerECCO '19
Year: 2019
Authors: Loris Riccardo Lopetuso
Ulcerative colitis, Colorectal cancer, Epithelial cell, Immunology, Mesenchymal cell
Files: 1
OP30: Serum proteomic profiling predicts and diagnoses pouchitis in ulcerative colitis patients undergoing ileal pouch-anal anastomosisECCO '19
Year: 2019
Authors: Kathleen Machiels
ANCA, ASCA, other serum markers, Colectomy, Ileo anal pouch procedure, Pouchitis, Proteomics
Files: 1
Page: () 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 ... 56 ()